These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7576291)

  • 61. Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma?
    Baba M; Natsugoe S; Shimada M; Nakano S; Shirao K; Kusano C; Fukumoto T; Aikou T
    Jpn J Thorac Cardiovasc Surg; 1999 May; 47(5):199-203. PubMed ID: 10402766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined modality therapy of esophageal carcinoma.
    Kelsen DP; Ahuja R; Hopfan S; Bains MS; Kosloff C; Martini N; McCormack P; Golbey RB
    Cancer; 1981 Jul; 48(1):31-7. PubMed ID: 6165456
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thermo-chemo-radiotherapy of esophageal cancer. A preliminary report of 34 cases.
    Hou BS; Xiong QB; Li DJ
    Cancer; 1989 Nov; 64(9):1777-82. PubMed ID: 2477135
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Early results with combined modality therapy for carcinoma of the esophagus.
    Wolfe WG; Burton GV; Seigler HF; Crocker IR; Vaughn AL
    Ann Surg; 1987 May; 205(5):563-71. PubMed ID: 3579403
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of locoregional esophageal cancer.
    Forastiere AA
    Semin Oncol; 1992 Aug; 19(4 Suppl 11):57-63. PubMed ID: 1509282
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bypass operation for advanced esophageal cancer--an analysis of 93 cases.
    Hirai T; Yamashita Y; Mukaida H; Kawano K; Toge T; Niimoto M; Hattori T
    Jpn J Surg; 1989 Mar; 19(2):182-8. PubMed ID: 2724717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapy of esophageal carcinoma. Results from the Joint Group on Esophageal Carcinoma in Rotterdam.
    van Andel JG; Dees J; Eijkenboom WM; van Houten H; Jobsen JJ; Mud HJ; Obertop H; van Putten WL; van Blankenstein M; Eeftinck Schattenkerk M
    Acta Radiol Oncol; 1986; 25(2):115-20. PubMed ID: 2424277
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Flow cytometric DNA analysis does not predict the radiochemoresponsiveness of esophageal cancer.
    Segalin A; Ruol A; Panozzo M; Bonavina L; Bianchi LC; Peracchia A
    J Surg Oncol; 1993 Oct; 54(2):87-90. PubMed ID: 8412165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Endocrine cell carcinoma of the esophagus without recurrence for more than 7 years after chemoradiotherapy].
    Midorikawa R; Ohchi T; Shigaki T; Kadoya K; Takahashi H; Shiratsuchi I; Hidaka A; Kusano H; Tanaka T
    Nihon Shokakibyo Gakkai Zasshi; 2019; 116(1):71-79. PubMed ID: 30626856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined modality therapy for oesophageal squamous cell carcinoma.
    Pedersen H; Hansen HS; Bertelsen S; Fischerman K
    Acta Oncol; 1987; 26(3):175-8. PubMed ID: 2443151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method.
    Ito H; Itasaka S; Sakanaka K; Araki N; Mizowaki T; Hiraoka M
    J Radiat Res; 2017 Jan; 58(1):106-113. PubMed ID: 27475126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of chemoradiotherapy for radiation-induced bilateral external auditory canal cancer: A case report and literature review.
    Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Ikeda A; Hirai R; Furusaka T; Homma T
    Head Neck; 2019 Jul; 41(7):E113-E119. PubMed ID: 30828909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Present status on treatment of esophageal cancer in China.
    Li DJ
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):477-84. PubMed ID: 2406232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Carcinoma of the esophagus. Observations of 40 years.
    Parker EF; Gregorie HB; Prioleau WH; Marks RD; Bartles DM
    Ann Surg; 1982 May; 195(5):618-23. PubMed ID: 7073359
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preoperative chemoradiotherapy for esophageal cancer.
    Kelsen D
    J Clin Oncol; 2001 Jan; 19(2):283-5. PubMed ID: 11208816
    [No Abstract]   [Full Text] [Related]  

  • 76. Brain of a Patient shown to the Section last year; the Patient having died some weeks after Operation.
    Mollison WM
    Proc R Soc Med; 1915; 8(Otol Sect):5-7. PubMed ID: 19978882
    [No Abstract]   [Full Text] [Related]  

  • 77. The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging.
    Chang EY; Li X; Jerosch-Herold M; Priest RA; Enestvedt CK; Xu J; Springer CS; Jobe BA
    J Gastrointest Surg; 2008 Jan; 12(1):166-75. PubMed ID: 17768665
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preoperative chemoradiotherapy for locoregional esophageal cancer: preliminary report.
    Kim SB; Kim SH; Lee KH; Lee JW; Kim SW; Suh CW; Lee JS; Song HY; Chang HS; Choi EK
    J Korean Med Sci; 1995 Apr; 10(2):111-20. PubMed ID: 7576291
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preoperative chemotherapy and radiotherapy for esophageal carcinoma.
    Naunheim KS; Petruska P; Roy TS; Andrus CH; Johnson FE; Schlueter JM; Baue AE
    J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.